TrialAnnals of clinical and translational neurology2021

Ataluren for drug-resistant epilepsy in nonsense variant-mediated Dravet syndrome and CDKL5 deficiency disorder.

Orrin Devinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.